Cover ImageSALE
市場調查報告書

流動轉移動脈瘤治療的全球市場:2018年∼2022年

Global Flow Diversion Aneurysm Treatment Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 366013
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
流動轉移動脈瘤治療的全球市場:2018年∼2022年 Global Flow Diversion Aneurysm Treatment Market 2018-2022
出版日期: 2018年07月02日 內容資訊: 英文 115 Pages
簡介

關於流動轉移動脈瘤治療

流動轉移動脈瘤治療,是使用流動轉移型支架(FDS)及腔內流動轉移分割設備等血管內設備的組成。這些設備,用於顱內動脈瘤(IA)的治療。

Technavio的分析師預測,從2018年到2022年之間,全球流動轉移動脈瘤治療市場將以14%的年複合成長率成長。

本報告提供全球流動轉移動脈瘤治療市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模(2017年)
  • 市場規模及預測(2017-2022年)

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:各產品
  • FDS
  • 不正確的流程破壞設備
  • 市場機會:各產品

第8章 客戶形勢

第9章 地區形勢

  • 各地區市場區隔
  • 地區比較
  • 歐洲、中東、非洲地區
  • 南北美洲
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 研究開發的強化
  • 擴大的適應症

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Acandis
  • Medtronic
  • Phenox
  • Stryker
  • Terumo Corporation

第15章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR22009

About flow diversion aneurysm treatment

Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).

Technavio's analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Flow Diversion Aneurysm Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acandis
  • Medtronic
  • Phenox
  • Stryker

Market driver

  • Increasing prevalence of IAs and associated risk factors
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness and access to flow diversion procedures in emerging countries
  • For a full, detailed list, view our report

Market trend

  • Increasing R&D focus
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • FDS
  • Intrasaccular flow disruption devices
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Flow diversion aneurysm treatment market in EMEA
  • Flow diversion aneurysm treatment market in Americas
  • Flow diversion aneurysm treatment market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing R&D focus
  • Expanding indications

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Acandis
  • Medtronic
  • Phenox
  • Stryker
  • TERUMO CORPORATION

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global neurovascular devices market
  • Exhibit 02: Global neurovascular devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global flow diversion aneurysm treatment market
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global flow diversion aneurysm treatment market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global flow diversion aneurysm treatment market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global flow diversion aneurysm treatment market - Market share by product 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global FDS market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global FDS market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global intrasaccular flow disruption devices market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global intrasaccular flow disruption devices market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global flow diversion aneurysm treatment market - Market share by geography 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Flow diversion aneurysm treatment market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Flow diversion aneurysm treatment market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Top two countries in EMEA
  • Exhibit 31: Flow diversion aneurysm treatment market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: Flow diversion aneurysm treatment market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top two countries in Americas
  • Exhibit 34: Flow diversion aneurysm treatment market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: Flow diversion aneurysm treatment market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top two countries in APAC
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Acandis - Overview
  • Exhibit 44: Acandis - Product segments
  • Exhibit 45: Acandis - Organizational developments
  • Exhibit 46: Acandis - Geographic focus
  • Exhibit 47: Acandis - Segment focus
  • Exhibit 48: Acandis - Key offerings
  • Exhibit 49: Acandis - Key customers
  • Exhibit 50: Medtronic - Overview
  • Exhibit 51: Medtronic - Business segments
  • Exhibit 52: Medtronic - Organizational developments
  • Exhibit 53: Medtronic - Geographic focus
  • Exhibit 54: Medtronic - Segment focus
  • Exhibit 55: Medtronic - Key offerings
  • Exhibit 56: Medtronic - Key customers
  • Exhibit 57: Phenox - Overview
  • Exhibit 58: Phenox - Product segments
  • Exhibit 59: Phenox - Organizational developments
  • Exhibit 60: Phenox - Geographic focus
  • Exhibit 61: Phenox - Segment focus
  • Exhibit 62: Phenox - Key offerings
  • Exhibit 63: Phenox - Key customers
  • Exhibit 64: Stryker - Overview
  • Exhibit 65: Stryker - Business segments
  • Exhibit 66: Stryker - Organizational developments
  • Exhibit 67: Stryker - Geographic focus
  • Exhibit 68: Stryker - Segment focus
  • Exhibit 69: Stryker - Key offerings
  • Exhibit 70: Stryker - Key customers
  • Exhibit 71: TERUMO CORPORATION - Overview
  • Exhibit 72: TERUMO CORPORATION - Business segments
  • Exhibit 73: TERUMO CORPORATION - Organizational developments
  • Exhibit 74: TERUMO CORPORATION - Geographic focus
  • Exhibit 75: TERUMO CORPORATION - Segment focus
  • Exhibit 76: TERUMO CORPORATION - Key offerings
  • Exhibit 77: TERUMO CORPORATION - Key customers
Back to Top